Mead Johnson Nutrition Company
2701 Patriot Boulevard
Fourth Floor
Glenview,
IL 60026
United States - Map
Phone: 847-832-2420
Web Site: http://www.mjn.com
| Mead Johnson Nutrition Company manufactures and markets infant formula and childrens nutrition products in North America, Latin America, Europe, and the Asia-Pacific. It offers formulas for routine feeding and mild intolerance; specialty formula products, including formulas for severe intolerance, and premature and low birth weight infants; and medical nutrition products. The company also offers products for infants with milk protein allergy, gas/fussiness, lactose intolerance, anti-regurgitation, severe protein sensitivity, multiple food allergies, and malabsorption. In addition, it offers childrens nutrition products, such as nutritious powdered milk for picky eaters, nutritious milk modifier, and pre-natal and post-natal nutritional supplements for expectant and nursing mothers. The company offers its products under Enfamil, Enfalac, Enfagrow, Enfapro, Enfakid, EnfaSchool, and Sustagen, Choco Milk, and Cal-C-Tose brand names. It offers its products to retail channels, including mass merchandisers, club stores, grocery stores, drug stores, and convenience stores. The company was founded in 1905 and is headquartered in Glenview, Illinois. Mead Johnson Nutrition Company is a subsidiary of Bristol-Myers Squibb Company. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Stephen W. Golsby , 55
Chief Exec. Officer, Pres |
$
1.16M |
$
0 | Mr. Peter G. Leemputte , 51
Chief Financial Officer and Sr. VP |
$
580.00K |
$
0 | Mr. Peter Kasper Jakobsen , 46
Pres of Americas Operations |
$
470.00K |
$
0 | Mr. Charles M. Urbain , 54
Pres of Asia & Europe Operations |
$
626.00K |
$
0 | Mr. Dirk H. Hondmann Ph.D., 43
Sr. VP of Global R&D |
$
481.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.23% Nasdaq 
1.35 (3.08%) 
Profile
